NAT9 Antikörper
-
- Target Alle NAT9 Produkte
- NAT9 (N-Acetyltransferase 9 (NAT9))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser NAT9 Antikörper ist unkonjugiert
-
Applikation
- Immunofluorescence (IF)
- Produktmerkmale
- Polyclonal Antibody
- Aufreinigung
- Affinity purification
- Immunogen
- Recombinant fusion protein of human NAT9 (NP_056469.2).
- Isotyp
- IgG
-
-
- Applikationshinweise
- IF 1:50-1:100
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Target
- NAT9 (N-Acetyltransferase 9 (NAT9))
- Andere Bezeichnung
- NAT9 (NAT9 Produkte)
- Synonyme
- EBSP, hNATL antikoerper, 1110028N05Rik antikoerper, N-acetyltransferase 9 (putative) antikoerper, N-acetyltransferase 9 (GCN5-related, putative) antikoerper, NAT9 antikoerper, Nat9 antikoerper
- Hintergrund
- NAT9 (N-Acetyltransferase 9 (Putative)) is a Protein Coding gene. Diseases associated with NAT9 include Lymphogranuloma Venereum and Granuloma Inguinale. Among its related pathways are Cytochrome P450 - arranged by substrate type. Gene Ontology (GO) annotations related to this gene include transferase activity, transferring acyl groups other than amino-acyl groups and N-acetyltransferase activity.
- Gen-ID
- 26151
- UniProt
- Q9BTE0
-